Bumetanide for Alzheimer’s disease

Alzheimer’s disease is the most common form of dementia, affecting up to 70% of all people with dementia.1 In the early stages, symptoms can...

‘Conservative’ King Review response

Health Minister Greg Hunt hints at no major shake-up, but trade-offs will be made. Attempting to allay fears of a major pharmacy sector shake-up, the...

Aged care royal commission welcomed by pharmacist sector

Following distressing reports of inappropriate medicine use in aged care homes, PSA National President Dr Shane Jackson has welcomed a royal commission into the...

Allergic rhinitis management

Are you aware that untreated allergic rhinitis (AR) can result in impaired driving performance similar to a blood alcohol level of 0.5% due to...

The role of pharmacists in home-based palliative care

While the majority of Australian palliative care patients want to be cared for and die at home, less than 10 per cent achieve that...

From the President: What opportunities have been unlocked?

PSA’s flagship plan Pharmacists in 2023 outlines system changes needed to unlock opportunities for pharmacists to be the best they can be.